| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 63.5961 | 66 |
| GSM780708 | Untreated after 4 days (C2_1) | 61.3065 | 65 |
| GSM780709 | Untreated after 4 days (C3_1) | 59.9678 | 64 |
| GSM780719 | Untreated after 4 days (C1_2) | 72.114 | 70 |
| GSM780720 | Untreated after 4 days (C2_2) | 63.468 | 66 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.5699 | 47 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 64.275 | 67 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 65.9029 | 68 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 71.0044 | 69 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 64.5751 | 67 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 63.6185 | 67 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 72.6654 | 70 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 66.9008 | 68 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 59.5181 | 64 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 68.3192 | 68 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 61.3356 | 65 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 55.1401 | 60 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 71.9058 | 70 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 57.4473 | 62 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 62.2744 | 66 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.333 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 63.1362 | 66 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 63.1733 | 66 |